• Health Economics Analyses for Medical Devices in Asia- A Literature Review

    Nov 1, 2016, 00:00

  • Economic Burden of Anti-Methicillin-Resistant Staphylococcus Aureus (Mrsa) Therapy in Public Hospitals of Paris (Ap-Hp) and Adequacy with the Defined Daily Doses

    Nov 1, 2016, 00:00

  • Current Trends in Methods of Pharmacoeconomic Studies of Cancer Therapies in China

    Nov 1, 2016, 00:00

  • Important Methodological Considerations and Strategies for Resolution for Multinational Retrospective Chart Review Studies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of National Screening Program for Pulmonary Tuberculosis in Korea

    Nov 1, 2016, 00:00

  • Effectiveness of Antiviral Therapy for Genotype 1 Chronic Hepatitis C in Real-World Patients from the Valencian Community (Spain)

    Nov 1, 2016, 00:00

  • Efficiency in Use of Lensx Vs Phacoemulsification Surgery for Cataract Treatment- Results from a Global Observational Study

    Nov 1, 2016, 00:00

  • Effective Use of Short-Term Healthcare By Immigrants In Chile- Linking Evidence To Policy For Universal Coverage

    Nov 1, 2016, 00:00

  • A Systematic Review Comparing Studies of Cardiovascular Event Utilities by Geographic Region

    Nov 1, 2016, 00:00

  • Effect of CVD on COPD Related Resource Utilization and Direct Medical Costs Among Statutory Heatlh Insured Patients In Germany

    Nov 1, 2016, 00:00

  • Health Insurance Treatment Cost of Colorectal Cancer in Hungary

    Nov 1, 2016, 00:00

  • Tasks Involved In Platelet Production And Transfusion From The U.S. Hospital Perspective- Two Process Frameworks

    Nov 1, 2016, 00:00

  • Evaluating The Experiential Quality of Older People's Community Care- A Concept Mapping Approach To Instrument Design

    Nov 1, 2016, 00:00

  • The Intergenerational Transmission of Adiposity Across Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Rifaximin-Α Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France

    Nov 1, 2016, 00:00

  • Cost Per Responder of Lixisenatide Versus Rapid-Acting Insulin Intensification Regimens in an Insulin-Exposed Type 2 Diabetes Mellitus (T2DM) Population

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer- A Net-Benefit Regression Approach

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure with Reduced Ejection Fraction- The Use of Model Calibration To Improve Generalisability To A UK CHF Population

    Nov 1, 2016, 00:00

  • The Longterm Cost Effectiveness of the “Coaching Patients on Achieving Cardiovascular Health” (Coach) Program in Type 2 Diabetes in Tasmania

    Nov 1, 2016, 00:00

  • Cost Variations of Inpatient, Daycare and Outpatient Hysteroscopy in A Tertiary-Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Predicted Demand For A New Injectable Solution For Delivering Glaucoma Medicine

    Nov 1, 2016, 00:00

  • The Coordination Of Care In Pmaq-Ab- An Analysis Based On The Item Response Theory

    Nov 1, 2016, 00:00

  • Missing the Value of Herd Immunity in Cost-Effectiveness Analysis. A Systematic Review

    Nov 1, 2016, 00:00

  • Patient Access to High-Cost and High-Value Specialty Products in China- Review of Decisions From Zhejiang, Neimenggu, Shandong and Jiangxi

    Nov 1, 2016, 00:00

  • Analysis of the Relationship Between Blood Pressure in Health Checkup and Effectiveness of Antihypertensives

    Nov 1, 2016, 00:00

  • Central Nervous System, Multiple Sclerosis And Social Security- The Economic Burden On The Social Security System Pensions In Italy

    Nov 1, 2016, 00:00

  • Analysis of Antibiotics’ Use in the Treatment of Tonsillopharyngitis in Children Population of Nis District

    Nov 1, 2016, 00:00

  • Assessment of Patient Preferences in the Treatment of Relapsing-Remitting Multiple Sclerosis in Public and Private Systems in Latin America

    Nov 1, 2016, 00:00

  • Have Budget Impact Analyses Included Clinical Outcomes?

    Nov 1, 2016, 00:00

  • Observational Study on Daily Life Practice in 15039 Patient with Multiple Sclerosis in France

    Nov 1, 2016, 00:00

  • Cost-Minimisation Analysis of Sucroferric Oxhydroxide and Sevelamer Carbonate in Patients on Dialysis with Secondary Hyperparathyroidism in Six European Countries

    Nov 1, 2016, 00:00

  • Effectiveness of Clinical Pharmacist Intervention on Direct Medical Cost in Chronic Obstructive Pulmonary Disorder Patients - A Randomized Controlled Study

    Nov 1, 2016, 00:00

  • Prospective Study of the Incidence, Nature and Causes of Dispensing Errors in Community Pharmacies of Ulaanbaatar, Mongolia

    Nov 1, 2016, 00:00

  • Self-Medication with Antibiotics in Sana'a City

    Nov 1, 2016, 00:00

  • Number Needed to Treat and Cost Per Clinically Meaningful Outcome of Enzalutamide and Abiraterone Acetate for The Treatment of Metastatic Castration-Resistant Prostate Cancer That Failed Androgen Deprivation Therapy in Brazil

    Nov 1, 2016, 00:00

  • Transcatheter Aortic Valve Implantation For Inoperable Severe Aortic Stenosis - A Meta-Analysis

    Nov 1, 2016, 00:00

  • Economic Evaluation of Olaparib In Patients with Brca – Mutated Psroc in Greece

    Nov 1, 2016, 00:00

  • Use of Real World Data in Identifying Relevant Comparators in Medico Economic Models at EU5 Level- A Case Study on Multiple Myeloma

    Nov 1, 2016, 00:00

  • 19th Euro - FDS Financial Disclosure Statements

    Nov 1, 2016, 00:00

  • Cost Effectivess Analysis for Combination of Aspirin and Warfarin Versus Warfarin Alone in Patients with Heart Valve Prosthesis

    Nov 1, 2016, 00:00

  • Economic Impact of Rivaroxaban use for Thromboembolic Events Prevention After HIP or Knee Replacement in Spain

    Nov 1, 2016, 00:00

  • The Effect of Traditional Medicine on Quality of Life in Patients with Atopic Dermatitis- A Review of Recent Clinical Trials

    Nov 1, 2016, 00:00

  • Economic Evaluation of Drug Therapy To Prevent Osteoporotic Fractures In Postmenopausal Women With Osteopenia

    Nov 1, 2016, 00:00

  • Advanced Therapy Medicinal Products (Atmps) In Europe 8 Years On- What Is The Path To Market Access So Far?

    Nov 1, 2016, 00:00

  • Forecasting Lifetime Health Outcomes and Costs of Treatment for Non-Alcoholic Fatty Liver Disease

    Nov 1, 2016, 00:00

  • The Burden of Selected Cancers in The United States- Health Behaviors and Healthcare Utilization of Survivors

    Nov 1, 2016, 00:00

  • Assessment of Adhesion Response To 3D Printed Materials For Ophthalmic Device Development

    Nov 1, 2016, 00:00

  • Direct Medical Resource Utilization For Reoperation After Intramedullary Fixation of Pertrochanteric HIP Fractures

    Nov 1, 2016, 00:00

  • Psychometric Validation of Anti-Clot Treatment Scale in Japanese Patients with Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Challenges in the Assessment of Medical Devices- Recommendations from the Medtechta Project

    Nov 1, 2016, 00:00

  • How much do the insured citizens know about the personal account of china's urban employees' basic medical insurance and what are their needs? Evidence from guizhou, china

    Nov 1, 2016, 00:00

  • Nintedanib Plus Docetaxel as Second-Line Therapy in Patients with Non-Small-Cell Lung Cancer (NSCLC)- A Network Meta-Analysis vs. New Therapeutic Options

    Nov 1, 2016, 00:00

  • Etiology and Outcome of Acute Kidney Injury in South Indian Population

    Nov 1, 2016, 00:00

  • Real Life Progression Free Survival and Treatment Patterns For Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapies in Fran Analysis of Ims Rwd Oncology Cross-Sectional Survey Data

    Nov 1, 2016, 00:00

  • Health State Utility Values (Hsuvs) Measured By The Euroqol 5-Dimensions (Eq-5d) Questionnaire In People Living With Hiv (Plhiv)- A Systematic Literature Review (Slr) Using Rapid Review Methodology

    Nov 1, 2016, 00:00

  • Comparative Efficacy of Time to Virologic Suppression in Treatment-Naive HIV-1 Patients- A Network Meta-Analysis of Longitudinal Data

    Nov 1, 2016, 00:00

  • Assessing The Economic Burden of Heart Failure in Korea- Incremental Cost Approach

    Nov 1, 2016, 00:00

  • Cost of Healthcare Among Metastatic Lung Cancer Patients Receiving Chemotherapy

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Active Surveillance of Beta-D-Glucan in Intensive Care Units in Hong Kong

    Nov 1, 2016, 00:00

  • The Economic Value of Olmesartan for The Treatment of Hypertensive Patients- A Systematic Review

    Nov 1, 2016, 00:00

  • Measuring Caregiver Quality of Life; Which Aspects Really Matter?

    Nov 1, 2016, 00:00

  • Cost-Utility of Denosumab For The Treatment of Postmenopausal Osteoporosis In Colombia

    Nov 1, 2016, 00:00

  • The American Society of Clinical Oncology (Asco) Net Health Benefit (Nhb) Assessment Tool- Which Implications for Value Assessment of Cancer Therapies?

    Nov 1, 2016, 00:00

  • Experiences And Attitudes Related To Screening of Patients Attended on A Colorectal Screening Pilot Program In Hungary

    Nov 1, 2016, 00:00

  • Could Amnog Become Irrelevant in the 21st century? Potential Redundancies in The Amnog Process in the ERA of Curative Therapies

    Nov 1, 2016, 00:00

  • Health Care Applicability of A Patient-Centric Web Portal For Patients' Medication Experience

    Nov 1, 2016, 00:00

  • Early Indicators of Patients with Major Depressive Disorder in Need of Highly Specialized Care- A Systematic Review

    Nov 1, 2016, 00:00

  • Choice of First Opioid Prescription and the Transitions from Acute to Long Term Opioid Use – Findings from Big Data

    Nov 1, 2016, 00:00

  • A New Accelerated Early Access Process for Diagnostics in France

    Nov 1, 2016, 00:00

  • Has Access To Innovative Therapies In Poland Improved Following The 2012 Reimbursement Act?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis For Treatment Of Parkinson’s Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Development of Antibiogram for Management of Aerobic Bacterial Infection in Diabetic Foot Ulcer

    Nov 1, 2016, 00:00

  • A Comparative Cost Analysis on Peritoneal Dialysis Versus Hemodialysis in Taiwan

    Nov 1, 2016, 00:00

  • The Good The Bad And The Non-Quantifiable – A Comparison of Rebates on Orphan Drugs Versus Non-Orphan Drugs In Germany

    Nov 1, 2016, 00:00

  • Using Evidence Reviews To Develop Focused Systematic Review Questions

    Nov 1, 2016, 00:00

  • Job Burnout Predictors In Community Pharmacists In Serbia

    Nov 1, 2016, 00:00

  • Estimating the contribution on the reduction of the burden of iron deficiency anemia from the current fortification strategy of commercial foods targeted to infants and toddlers in india. Scenarios using systematic review and real world evi ...

    Nov 1, 2016, 00:00

  • Invisible Lever for Access to Innovative Therapies in Bulgaria

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis to Estimate The Economic Consequences Of Introducing The Combination of Avastin + Tarceva for The Treatment of First Line Epidermal Growth Factor (EGFR) Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Nov 1, 2016, 00:00

  • Status of Orphan Drugs and Reimbursement Recommendations and Decisions in Analysed European Countries

    Nov 1, 2016, 00:00

  • Impact of Continuity of Care on Care And Costs For Chronic Disease

    Nov 1, 2016, 00:00

  • Global Evaluation of European Submission Template to Inform HTA and Payer Submissions

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment For Chronic Obstructive Pulmonary Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Characteristics, Resources Utilization And Safety Profile of Patients with Acute Pain- A European Real World Evidence Study

    Nov 1, 2016, 00:00

  • The Effect of Ras-Modifying Medications on Pulmonary Complications in Patients with Hypertension

    Nov 1, 2016, 00:00

  • Economic Burden of Varicella In Children In Poland, 2011–2015

    Nov 1, 2016, 00:00

  • Systematic Review of Health State Utilities Based on the Eq-5d in Studies of Lymphomas

    Nov 1, 2016, 00:00

  • Fore! Sweeping Generalisations do not Bowl Over all Cultures… Cultural Adaptation in the Kidney Disease Quality of Life Questionnaire

    Nov 1, 2016, 00:00

  • The Potential to Improve Inhalation Technique in Patients with Asthma Or Copd By Switching From Symbicort® Turbuhaler® (Budesonide + Formoterol) to Duoresp® Spiromax®- Estimated Impact on The Number and Cost of Unscheduled Healthcare Events ...

    Nov 1, 2016, 00:00

  • Economic Burden Of Primary Immunodeficiency In National Institute Of Pediatrics In Mexico

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis to Evaluate the Femtosecond Laser-Assisted Cataract Surgery in Children

    Nov 1, 2016, 00:00

  • A Pubmed Based Search on Cost Effectiveness and Health-Related Quality of Life Studies with Respect to Complementary and Alternative Medicines

    Nov 1, 2016, 00:00

  • Results From An on-Site Healthcare Provider Survey on Perceptions of Type 2 Diabetes Treatment

    Nov 1, 2016, 00:00

  • Access To New Drugs After The Introduction Of The 2011 Reimbursement Act In Poland

    Nov 1, 2016, 00:00

  • Annual Cost and Effects of Switching to Insulin Degludec from Other Basal Insulins- Evidence from Swedish Real-World Data

    Nov 1, 2016, 00:00

  • Pharmacoutilization In Patients Suffering From Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • How Beneficial Is Hrqol Assessment In The Course Of Treatment Decisions In Physical Rehabilitation? Results Of Clinicians' Perspective

    Nov 1, 2016, 00:00

  • Deterministic Vs Microsimulation; A Case Study In Systemic Lupus Erythematosus (SLE)

    Nov 1, 2016, 00:00

  • Antithrombotic Treatment Pattern in Patients with Atrial Fibrillation in Italy Before and After Xaban/Dtis Launch- The Repair Study Cross-Sectional Results

    Nov 1, 2016, 00:00

  • A Preliminary Cost-Utility Analysis of Non-Invasive Vagus Nerve Stimulation Therapy in Patients Suffering with Headache and Functional Disorder Multi-Morbidity

    Nov 1, 2016, 00:00

  • Hcv Treatment with Daas in the ‘Real-World’- How Well Do ‘Real’ Patients Respond? The Irish Perspective

    Nov 1, 2016, 00:00

  • Impact of Inadequate Insulin Resuspension (IIR) on Clinical, Patient And Economic Outcomes- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Increasing Efficiency of Pricing and Market Access Decisions By Cross Functional Interactions

    Nov 1, 2016, 00:00

  • Assessment Of Various Factors Influencing Quality Of Life In Pcos Patients Of Northern Telangana Region Of India

    Nov 1, 2016, 00:00

  • Antineoplastic Drug Expenditure in Panama 2012-2014

    Nov 1, 2016, 00:00

  • Comparative Analysis of The Guidelines for Conducting Hta in Poland and Bulgaria

    Nov 1, 2016, 00:00

  • The European Social Preference Measurement (ESPM) Study- Conceptual Considerations and Implementation

    Nov 1, 2016, 00:00

  • Influence of Perceived Risk on Willingness to Pay for Diagnosis of Cardiovascular Diseases

    Nov 1, 2016, 00:00

  • The Guardians' Choices And Preferences For Imported Surrogate Vaccines In China- Based On A Survey In Shenyang, Liaoning Province

    Nov 1, 2016, 00:00

  • Cost Analysis of Levofloxacin 750mg During 5 Days Vs Levofloxacin 500mg During 10 Days for the Treatment of Comunity-Acquired Pneumonia Under the Brazilian Public Hospital Perspective

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Exercise for the Prevention of Cancer

    Nov 1, 2016, 00:00

  • Effective Use of Long-Term Healthcare In Chile- Are International Migrants At Disadvantage of Universal Health Coverage

    Nov 1, 2016, 00:00

  • Comparison of Equity Weights of Various Adverse Consequences of Tobacco Use- A Best-Worst Scaling for Two Types of Chinese General Public

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China

    Nov 1, 2016, 00:00

  • Adverse Events Associated with Intravenous Immunoglobulin in Thailand

    Nov 1, 2016, 00:00

  • Drug Pricing And Reimbursement Processes In Algeria

    Nov 1, 2016, 00:00

  • An Assessment of The Number of Chronic Lymphocytic Leukemia (CLL) Patients Eligible For Front-Line Treatment But Unsuitable For Full-Dose Fludarabine Across The European Union

    Nov 1, 2016, 00:00

  • Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated With Infliximab, Etanercept And Adalimumab In Nordic Setting

    Nov 1, 2016, 00:00

  • Comparison of Cost-Effectiveness Between Egfr-Tkis Therapy and Chemotherapy for Advanced Nsclc

    Nov 1, 2016, 00:00

  • Mapping the Irritable Bowel Syndrome Quality of Life Measure (IBS-QOL) to EQ-5D in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)

    Nov 1, 2016, 00:00

  • Are treatment sequences, adverse events, long-term disease progression adequately considered in cost-effectiveness analyses of rheumatoid arthritis ?- A critical economic litterature review

    Nov 1, 2016, 00:00

  • How Gifts and Brand Reminders Influence the Generic Brand Selection Among Physicians?

    Nov 1, 2016, 00:00

  • Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?

    Nov 1, 2016, 00:00

  • A Study on Drug Utilization and Drug Related Proplems Among Anti-Ulcer Patiend Admitted in Teaching Hospital

    Nov 1, 2016, 00:00

  • Helping Decision-Makers Visualize Inequities In Health Impact Assessment- Linked Electronic Records, Mortality And Regional Disparities In Portugal

    Nov 1, 2016, 00:00

  • The Emerging Roles of Pharmacists in Selected Tertiary Hospitals in Pangasinan and La Union- Focus on Pharmaceutical Care and Pharmacovigilance

    Nov 1, 2016, 00:00

  • The Association Between Loneliness and Healthcare Utilization Among Older Adults in Singapore

    Nov 1, 2016, 00:00

  • The Hector Study- Health Economics Study of Codeine And Tramadol Non-Responders – A Sub Population Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Internet-Delivered Cognitive Behavior Therapy for Adolescent Obsessive-Compulsive Disorder

    Nov 1, 2016, 00:00

  • Comparison of Medical Costs, Health Care Utilization, and Health Outcomes Between the Elderly with and Without Disabilities in Korea

    Nov 1, 2016, 00:00

  • Survival and Resource use in The Treatment of Metastatic Renal Cell Carcinoma in Sweden- A Retrospective Analysis of Data from National Registries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir In Treatment Of Chronic Hepatitis C In The Russian Federation

    Nov 1, 2016, 00:00

  • Comparison of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening- A Systematic Review

    Nov 1, 2016, 00:00

  • Economic Evaluation of The Portuguese Needle Exchange Programme In Community Pharmacies (NEP-CP)

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Treatment Strategies For Multiple Myeloma in Elderly Patients- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Healthcare Expenditures and Equity in Healthcare Utilization for Lymphedema Patients in France

    Nov 1, 2016, 00:00

  • Societal And-Economic Burden of Iron Deficiency Among Swiss Women – Results from a Household Survey

    Nov 1, 2016, 00:00

  • Chemotherapy, Cytokines and Cancer-Related Fatigue- A Systematic Review of Quantitative Studies in 1312 Patients

    Nov 1, 2016, 00:00

  • EQ-5D Studies in Diseases of The Circulatory System in Eight Central and Eastern European Countries

    Nov 1, 2016, 00:00

  • Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy- Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems

    Nov 1, 2016, 00:00

  • The Public Health And Economic Impact Of Gender Neutral Quadrivalent Human Papillomavirus Vaccination Program In Brazil

    Nov 1, 2016, 00:00

  • Spill Over Economic Impacts on Families of Children Receiving Hospital-Based Care

    Nov 1, 2016, 00:00

  • Simulating Patient-Level Profiles To Capture Patient Heterogeneity In Health-Economic Applications

    Nov 1, 2016, 00:00

  • Rheumatoid Arthritis is Associated with an Increased Risk of Depression in Elderly Patients in Germany

    Nov 1, 2016, 00:00

  • Comparative Efficacy and Saftey of Interventions in The Treatment of Advanced Soft Tissue Sarcoma- A Systematic Review and Network Meta Analysis

    Nov 1, 2016, 00:00

  • Direct Costs Of Epilepsy In Turkey- A Panel Approach

    Nov 1, 2016, 00:00

  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon

    Nov 1, 2016, 00:00

  • Identifying Higher-Value Subpopulations For Treatment In Heterogenous Rare Diseases- An Example Study of Early Responders to Teduglutide for Short Bowel Syndrome

    Nov 1, 2016, 00:00

  • International Reference Pricing's Evolution In China

    Nov 1, 2016, 00:00

  • The Evaluation Health Education to Elevate Correct Medication Knowledge and Ability in Community

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Bariatric Surgery in Germany, France, Italy and the United Kingdom

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Depends on the Subsequent Treatment Sequen An Example from Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Cost Comparison of Wet Age-Related Macular Degeneration Treatment with Aflibercept or Ranibizumab

    Nov 1, 2016, 00:00

  • In-Licensing as a Business Strategy for Pharmaceutical Companies- A Framework for the Nigerian Industry

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban Versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • The Coeliac Disease Assessment Questionnaire (Cdaq)- Development of a Patient-Reported Outcome Measure

    Nov 1, 2016, 00:00

  • Patients’ Preferences Toward Characteristics of Treatment with Biological Agents Differ According to Experience with their Rheumatic Disease and Treatment Received or Prescribed- Results from the Cara Study

    Nov 1, 2016, 00:00

  • Impact of National Orphan Drug Policy and Reimbursement Mechanisms Over the Implementation of Managed Entry Agreements in Select Asia-Pacific Countries

    Nov 1, 2016, 00:00

  • The Use of ‘Off The Shelf’ Informative Prior Distributions In Random Effect Network Meta-Analysis Models

    Nov 1, 2016, 00:00

  • Systematic Literature Review to Assess Prevalence of Gina-Defined Segments of Asthma and Phenotypes

    Nov 1, 2016, 00:00

  • Epidemiology of Patients Receiving Hematopoietic Stem Cell Patients in Belgium

    Nov 1, 2016, 00:00

  • Evaluating The Cost-Benefit of A Cognitive Assessment and Training Program Across A Smart City Population in The UK

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland

    Nov 1, 2016, 00:00

  • Quick Assessment on Lung Cancer Screening with Low-Dose Computed Tomography

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation is Associated with Phase of Chronic Myeloid Leukaemia (CML)- Results of a Clinical Expert Survey in England and Wales

    Nov 1, 2016, 00:00

  • Association Between Stages of Change and Medication Adherence Among Diabetic Patients in a Primary Health Care Setting in Qatar- A Preliminary Study

    Nov 1, 2016, 00:00

  • Mepolizumab For The Treatment of Chronic Asthma. A Meta-Analysis of Randomized Placebo-Controlled Trials

    Nov 1, 2016, 00:00

  • Age and Gender Specific Trends in Acute Inpatient Stroke Incidence in Germany

    Nov 1, 2016, 00:00

  • Implication Of External Price Referencing On Pharmaceutical List Prices In Europe

    Nov 1, 2016, 00:00

  • Costs of Perennial Allergic Rhinitis And Asthma Increase with Level of Severity And Level of Disease Control

    Nov 1, 2016, 00:00

  • Eq-5d Studies In Nervous System Diseases In Eight Central And Eastern European Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Type 2 Diabetes (T2DM) Treatment with Dapagliflozin as Add-On to Metformin in the Dominican Republic and Guatemala

    Nov 1, 2016, 00:00

  • Reviewing the Economic Impact of Extending the National Immunization Program in Egypt

    Nov 1, 2016, 00:00

  • Review of Multicriteria Decision Analysis Application for Decision-Making in Oncology

    Nov 1, 2016, 00:00

  • Business Intelligence for Detecting Possible Surgical Site Infections from Gallbladder Surgery (Chol) and Colon Surgery (Colo) in Ramathibodi Hospital, Thailand

    Nov 1, 2016, 00:00

  • THE IMPACT OF THE ECONOMIC CRISIS ON THE INCIDENCE AND INTENSITY OF CATASTROPHIC HEALTH PAYMENTS IN GREECE

    Nov 1, 2016, 00:00

  • Economic Evaluation for the United Kingdom of Systemic Chemotherapies as First-Line Treatment for Metastatic Pancreatic Cancer

    Nov 1, 2016, 00:00

  • A Prospective Analysis of Adverse Drug Reaction in A Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Dimethyl Fumarate Versus Fingolimod And Teriflunomide In Patients With Relapsing-Remitting Multiple Sclerosis In Colombia

    Nov 1, 2016, 00:00

  • The Cost of Asthma In Italy

    Nov 1, 2016, 00:00

  • The Association of Adherence to Disease-Modifying Drugs and Out-of-Pocket Costs in Patients with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Kidney-Related Complications Are Associated With Worse Outcomes Among Hospitalized Children With Autosomal Dominant Polycystic Kidney Disease In The US

    Nov 1, 2016, 00:00

  • Response to Targeted Therapy and Healthcare Resource Utilization (HRU)- A European Retrospective Chart Review Study in Patients With HER2+ Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Diabetes Self-Management- Pharmacy Perspective

    Nov 1, 2016, 00:00

  • A Review Of The Quality And Accuracy Of Budget Impact Models For High Cost Drugs In Ireland

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis (MCDA)- Common Tools for Different Needs Supporting Healthcare Decision Making in Spain

    Nov 1, 2016, 00:00

  • Timing of Insulin Injections Predicts Type 2 Diabetes Control and Adherence in a Multinational Sample

    Nov 1, 2016, 00:00

  • An Assessment of The Relative Efficacy of Sodium Glucose Co-Transporter 2 Inhibitors As Add-On To Metformin In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Defining Real-World Product Performance Using Survival Analysis and Superivsed Machine Learning

    Nov 1, 2016, 00:00

  • Proqolid Database- Evolution Of Content, Structure, And Functionalities (2012-2016) - Integration In Eprovide, A New Online Platform Dedicated To Clinical Outcome Assessment (Coa) Research

    Nov 1, 2016, 00:00

  • Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Western Europe

    Nov 1, 2016, 00:00

  • Economic Analyses of Flair® and Fluency® Plus Endovascular Stent Grafts for the Treatment of Vascular Access Stenosis- A U.S. Hospital and Payer Perspective

    Nov 1, 2016, 00:00

  • Predicting Length Of Stay After Road Traffic Accident Accounting For Competing Endpoints With Time-Dependent Variables

    Nov 1, 2016, 00:00

  • Cost of Treatment of Actinic Keratosis on the Face/Scalp in Sweden

    Nov 1, 2016, 00:00

  • Comparison of Direct Healthcare Costs Associated with Chronic Spontaneous /Idiopathic Urticaria in 7 Countries - Results from the Assure-CSU Study

    Nov 1, 2016, 00:00

  • Variation of Data Source Used for Baseline Population and for Natural Course of Alzheimer's Disease Progression in Model-Based Economic Evaluation of Treatment of AD

    Nov 1, 2016, 00:00

  • Advanced Therapies- Widening The Gap Between Payers And Regulators

    Nov 1, 2016, 00:00

  • Using Subpopulation Treatment Effect Pattern Plot to Identify More Efficient Resource Allocation Policies

    Nov 1, 2016, 00:00

  • Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Japan

    Nov 1, 2016, 00:00

  • Costs, Outcomes And Uses Of New Drugs- Drug Assessment Reports Vs Real World Data

    Nov 1, 2016, 00:00

  • Association Between Disease Prevalence, Drug Price and ASMR for Orphan Drugs in France

    Nov 1, 2016, 00:00

  • Implications of Price Erosion of Docetaxel After Loss of Exclusivity on Cost-Effectivess

    Nov 1, 2016, 00:00

  • Assessment of Biosimilar Landscape in Korea, Malaysia, Singapore and Taiwan

    Nov 1, 2016, 00:00

  • Use of A Claims Database To Document The Use and Effectiveness of Oral Vinorelbine (NVBO) in A Real World Setting France

    Nov 1, 2016, 00:00

  • The Cost Of Treating Mucormycosis With Isavuconazole Compared With Liposomal Amphotericin B Followed By Posaconazole In The United Kingdom- Economic Evaluation Of The Phase Iii Vital Study And Fungiscope Matched Case-Control Analysis

    Nov 1, 2016, 00:00

  • A Cross-National Comparison Of The Effect Of Age And Gender On Health-Related Quality Of Life (Hrql)

    Nov 1, 2016, 00:00

  • Comprehensive Evaluation of The Disease Burden Associated with Hemophilia A In China

    Nov 1, 2016, 00:00

  • Work Productivity and use of Disease-Modifying Therapies in Multiple Sclerosis- Results From A Patient Survey Accessed Through Social Media

    Nov 1, 2016, 00:00

  • Evaluation of The Economic Impact of Ferric Carboxymaltose Use For The French National Health Insurance And The French Hospitals Organization

    Nov 1, 2016, 00:00

  • Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors

    Nov 1, 2016, 00:00

  • Review of Insulin Listing in the National Drug Formulary of Malaysia

    Nov 1, 2016, 00:00

  • Determining The Clinical Practice And Resource Use Associated To The Diagnosis And Treatment Of Clostridium Difficile Infection In Mexico

    Nov 1, 2016, 00:00

  • Hemoglobin A1C (A1C) Reduction And Diabetes-Related Health Care Costs Among Type 2 Diabetes (T2DM) Patients Treated With Liraglutide or Exenatide- A Retrospective Claims Database Analysis

    Nov 1, 2016, 00:00

  • The Accuracy of Patient Self Report in Measuring Continuity of Care in Australia

    Nov 1, 2016, 00:00

  • Cost-of-Illness of Metastatic Gastroenteropancreatic Neuroendocrine Tumours In Sweden – A Register-Linkage Population-Based Study

    Nov 1, 2016, 00:00

  • The Impact of Rifaximin-A on Non-Elective Hospital Admission and Attendance Costs in Uk Patients with Hepatic Encephalopathy

    Nov 1, 2016, 00:00

  • Development and Evaluation of Patient Information Leaflets for Diabetic Foot Ulcer Patients

    Nov 1, 2016, 00:00

  • Zinforo (Ceftaroline Fosamil) Versus other Empiric Antibiotics for Moderate-to-Severe Community Acquired Pneumonia (CAP) In Adults- a Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Key Drivers of HTA Decisions for “Life-Changing” Drugs

    Nov 1, 2016, 00:00

  • Network Meta-Analysis Comparing Palbociclib with Chemotherapies For Treatment of Postmenopausal Women With HR+/ HER2- Advanced/ Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Differentiation Of Health Related Quality Of Life Outcomes Between Patient Populations; Results From Patients With Breast Cancer, Rheumatoid Arthritis, Multiple Sclerosis, Rare Cancers And Rare Diseases

    Nov 1, 2016, 00:00

  • Is there Evidence of a Difference Between Willingness to Pay and Willingness to Accept Thresholds? A Review of Nice Technology Appraisals

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications and Relapse

    Nov 1, 2016, 00:00

  • Early Market Access for Pharmaceuticals in EU- What is the Impact of Ema’s Accelerated Assessment Procedure?

    Nov 1, 2016, 00:00

  • The Economic Burden of Schizophrenia in Malaysia

    Nov 1, 2016, 00:00

  • Spatial Distribution of the Total Number of Medical Devices in Turkey- A Classification Analysis

    Nov 1, 2016, 00:00

  • Do Health Technology Agencies Accept Methods for Dealing with Treatment Switching and Immature OS Data?

    Nov 1, 2016, 00:00

  • The Use Of Administrative Data To Determine Prevalence And Incidence Of Copd- A Systematic Review

    Nov 1, 2016, 00:00

  • Impact of National Criteria and Healthcare System Characteristics on Access to Biologic Dmards in Rheumatoid Arthritis In Europe

    Nov 1, 2016, 00:00

  • Making Sense of Clinical Data Reported in Secondary Conditions- The Epidemiology and Clinical Burden of Hyperglycaemia

    Nov 1, 2016, 00:00

  • International Reference Pricing Across EU

    Nov 1, 2016, 00:00

  • Participation Of External Medical Societies In The Benefit Assessment Of Pharmaceuticals In Germany

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of the Pharmacist-Assisted Warfarin Monitoring Program (PAWM) at a Medical Center in Taiwan

    Nov 1, 2016, 00:00

  • The Cancer Drugs Fund- The Evolving Assessment Process

    Nov 1, 2016, 00:00

  • Development of a Responder Definition for the Migraine Physical Function Impact Diary (MPFID)

    Nov 1, 2016, 00:00

  • Development of a Mapping Algorithm Between the SGRQ and EQ-5D-5L Utility Values in a Severe Asthma Population

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Opioid use Disorder Measured by Utilities- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • The Economic Impact of Tobacco Smoking In The Latin-American Healthcare Systems- A Study Conducted In Seven Countries And Its Extrapolation At The Regional Level

    Nov 1, 2016, 00:00

  • Direct Medical Cost and Healthcare Resource Utilization in Elderly Patients with Type 2 Diabetes Mellitus Among Insured Urban Population in China

    Nov 1, 2016, 00:00

  • A Prospective Study of Antihypertensive Drugs Utilization Pattern in Outpatients of a Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Comparative Exploratory Analysis on Effectiveness, Tolerability And Patient/Nurse Satisfaction With Two Non-Invasive Patient Controlled Analgesia Treatments For Acute Post-Operative Pain Management

    Nov 1, 2016, 00:00

  • Assure-Csu- Resource Use and Economic Burden in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria in Italy

    Nov 1, 2016, 00:00

  • Pay For Performan A Proposal For And Simulation Of Real Time Outcomes-Based Pharmaceutical Pricing Using Routinely Collected Data

    Nov 1, 2016, 00:00

  • Spiralling Healthcare Expenditure in Malaysia- Is it Sustainable?

    Nov 1, 2016, 00:00

  • Choosing First-Line Treatment of Metastatic Colorectal Cancer Based on Biomarker Ras Status- A Budget Impact Analysis From Brazilian Health Insurance System Perspective

    Nov 1, 2016, 00:00

  • Health Resource Use and Cost Under Pay on Fee and Case-Based Payment in Hospitalized Patients with Chronic Obstructive Pulmonary Disease in China

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Ketoconazole Versus Metyrapone for the Treatment of Cushing’s Syndrome in a Swedish Setting

    Nov 1, 2016, 00:00

  • The Association with Psychiatric Diseases and Patients with Chronic Spontaneous Urticaria in Taiwan

    Nov 1, 2016, 00:00

  • Hospital Resource Utlization of Patients Over 40 Years old with Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2016, 00:00

  • Are Allocation Preferences In Health Care Consistent With A Particular Definition Of Severity? Results From A Random-Sample Survey Of Norwegians

    Nov 1, 2016, 00:00

  • Impact of Initiation of Long-Acting Injectable Antipsychotics on Resource Utilization In Patients with Schizophrenia

    Nov 1, 2016, 00:00

  • Assessing the Gap Between Prioritized Conditions and Covered Conditions in Current Legislation for Rare and Orphan Diseases in Peru

    Nov 1, 2016, 00:00

  • The value of timely implementation in hiv/sti testing- cost-effectiveness vs. Speed of intervention rollout

    Nov 1, 2016, 00:00

  • Good Cop, Bad Cop; G-BA and Iqwig in Clinical Outcome Evaluations

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Guanfacine Extended-Release Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant

    Nov 1, 2016, 00:00

  • Innovative Therapies for The Treatment of Cancer- An Overview of Late-Phase Clinical Development

    Nov 1, 2016, 00:00

  • Which Medical Device for Urinary Incontinence Provides Patient The Higher Quality of Life?

    Nov 1, 2016, 00:00

  • Trends in Health Technology Assessments since the Introduction of Cost-Effectiveness in the Netherlands

    Nov 1, 2016, 00:00

  • Is There A Difference In Perception And Practice In Pharmacological Management Of Schizophrenia- A Cross Sectional Survey In India

    Nov 1, 2016, 00:00

  • The Pareto Principle ("80−20 Rule") In Healthcare Services In Greece

    Nov 1, 2016, 00:00

  • Derivation and External Validation of an Early Readmission Risk Prediction Model

    Nov 1, 2016, 00:00

  • Prediction of the Morbidity with Bacterial Purulent Meningitis of Various Origin with Consideration of the Existing Vaccine Prevention Procedures

    Nov 1, 2016, 00:00

  • A Propensity Score Matched Study of Plasmablade Vs Coblation Technology During Pediatric Tonsillectomy and Adenoidectomy Procedures

    Nov 1, 2016, 00:00

  • The Cost Of Multiple Sclerosis In 16 European Countries- Functional Status, Symptoms And Mental Factors Drive Costs

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Treatment for Recurrent Malignant Glioma in Romania

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results from a Survey of Clinicians in Six European Countries

    Nov 1, 2016, 00:00

  • The Impact of Extrapolating Survival Based on Cure Models- Comparing Mean Incremental Survival and Cure Rates in Different Datasets

    Nov 1, 2016, 00:00

  • Diffusion of Trans-Arterial Radioembolization for The Treatment of Intermediate-Advanced Hepatocellular Carcinoma in Italy- A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Systematic Review and Network Meta-Analysis (Nma) in Reimbursement Submission; What Nice Says Versus what Nice Wants

    Nov 1, 2016, 00:00

  • The Burden of Depression in Japan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Threshold Proposal For Bosnia And Herzegovina

    Nov 1, 2016, 00:00

  • Impact of Adoption of A New Drug on the Trends in Utilization Patterns Changes and Pharmaceutical Expenditure- An Example of Urate-Lowering Therapy

    Nov 1, 2016, 00:00

  • Measures of Clinical Benefit in Immuno-Oncology Studies

    Nov 1, 2016, 00:00

  • Gout Diagnosis and Possible Increased Risk of Joint Replacement- A Population-Based Cohort Study of Older Adults

    Nov 1, 2016, 00:00

  • Market Access of Innovative Anticancer Drugs in Algeria- Funding Based on Clinical or Economic Evidence?

    Nov 1, 2016, 00:00

  • Systematic Literature Review and Assessment of the Reporting Quality of Economic Evaluation Studies in Non-Small Cell Lung Cancer in China

    Nov 1, 2016, 00:00

  • Assessment of Prescribing Indicators in Public and Private Primary Health Care Facilities in Indonesia

    Nov 1, 2016, 00:00

  • Experience Seeking Appropriate Standards of Cost-Effectiveness Ratio- Updates and Challenges in Japanese Setting

    Nov 1, 2016, 00:00

  • Adherence of Patients with Type 2 Diabetes to Medications – The Role Of Risk Preferences

    Nov 1, 2016, 00:00

  • Barriers Influencing Implementation of Guidelines Into Clinical Practice in Czech Republic

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Brca Mutation Testing for Early-Stage Breast Cancer Patients with Family History in Malaysia

    Nov 1, 2016, 00:00

  • Biosimilars- Market Access and Market Penetration – A Comparison of France and Germany

    Nov 1, 2016, 00:00

  • Cost of 1st Line Treatment Failure in Braf V600 Mutated Metastatic Melanoma in France

    Nov 1, 2016, 00:00

  • Factors Affecting Prolonged Length of Stay In Patents With Mood Disorders

    Nov 1, 2016, 00:00

  • Utilities Associated with The Number of Days on Parenteral Support in The Treatment of Short Bowel Syndrome

    Nov 1, 2016, 00:00

  • Increased Clinical and Economic Benefit in Spain Associated with Improvement to ±8.5% of The Accuracy of Glucose Meters Adapted to The Current ISO 15197-2013 (±15%)

    Nov 1, 2016, 00:00

  • Considering or Not Adverse Events in Health Economic Models- A Pragmatic Approach

    Nov 1, 2016, 00:00

  • The Impact of Atrial Fibrillation on the Economic Burden of Ischemic Stroke Patients in Beijing

    Nov 1, 2016, 00:00

  • The Effect of Acne on The Quality of Life In Bulgaria - Pilot Study

    Nov 1, 2016, 00:00

  • Sleeping Pills Use Among Adults in Israel

    Nov 1, 2016, 00:00

  • Economic Evaluation of Dengue Vaccination in Bangkok Metropolitan Administration

    Nov 1, 2016, 00:00

  • Developing A Small Cell Lung Cancer Conceptual Model to Inform Treatment Outcome and Assessment Strategy Decisions in Clinical Research

    Nov 1, 2016, 00:00

  • High Prevalence But Poor Awareness And Knowledge of Atrial Fibrillation Among The Elderly In Hong Kong

    Nov 1, 2016, 00:00

  • Use of Internet and Reliability of Information Obtained Online Concerning Medication Risks/Safety- Perceptions of Consumers in the U.S

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of National Cervical Cancer Screening Program in Denmark- Cytology with HPV triage vs. HPV Primary Screening with Reflex Cytology Triage Cintec Plus Cytology

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Treatment of Adult Patients with Severe Uncontrolled Asthma with Omalizumab In Russia

    Nov 1, 2016, 00:00

  • Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents- An Exploratory Evaluation using Advanced Hierarchical Network Meta-Analysis Techniques

    Nov 1, 2016, 00:00

  • Impact and Importance of Real World Data in Asia- A Physician's Perspective

    Nov 1, 2016, 00:00

  • assessment Of Willingness To Pay For Consultaion And Diagnostic Services In Sheikh Khalifa Bin Zayyed Al-Nayyan Medical Complex, Quetta

    Nov 1, 2016, 00:00

  • The Use Of Pharmacoeconomic Evidence To Encourage Generic Medicines Use In Jordan- A Cost Minimization Analysis

    Nov 1, 2016, 00:00

  • Adherence, Healthcare Resource Utilization and Direct Medical Costs Among Patients with Alzheimer's Disease in Tianjin, China

    Nov 1, 2016, 00:00

  • The Impact On Societal Burden Of Changed Uptake Of Hormonal Treatments

    Nov 1, 2016, 00:00

  • Analysis of Affordability and Consumption of Statins in Ukraine in 2015

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of The Introduction Of Darunavir 800 Mg Qd For The 2nd Line Treatment Of Hiv-Infected Treatment-Experienced Adults On The Brazilian National Hiv Program

    Nov 1, 2016, 00:00

  • The Humanistic and Economic Burden of Irritable Bowel Syndrome with Diarrhoea (IBS-D) by Disease Severity among Patients in The EU5 Region

    Nov 1, 2016, 00:00

  • The Relationship Between Regret In Patient Decision-Making During The Clinical Process And Patient Factors—Tests Based On The Japanese Version Of The Decision Regret Scale(Drs)—

    Nov 1, 2016, 00:00

  • Access to New Health Technologies in The Brazilian Health System- Disseminating Information to Law Operators for Qualifying The Health Decisions

    Nov 1, 2016, 00:00

  • Heterogeneous Preferences For Delaying Onset Of Alzheimer’s Disease Among Older Adults In The Us

    Nov 1, 2016, 00:00

  • A Framework For Measuring Adherence To Multiple Medications

    Nov 1, 2016, 00:00

  • key Drivers for Market Penetration of Biosimilars in Europe

    Nov 1, 2016, 00:00

  • Development Of Day Surgery In Hungary Between 2004-2014

    Nov 1, 2016, 00:00

  • Red and Processed Meat Intake Perception in the Portuguese Population- Association with the WHO Alert of 2015 – Preliminary Results of the Malert Study

    Nov 1, 2016, 00:00

  • Annual Cost of Illness of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO) in Turkey

    Nov 1, 2016, 00:00

  • Statistical Models to Predict Indication of Respiratory Patients Between Asthma and COPD

    Nov 1, 2016, 00:00

  • Real World Evidence in Europe- A Snapshot of its Current Status

    Nov 1, 2016, 00:00

  • A Real World Cost Analysis of Serum Hbsag Quantification Test in Patients with Chronic Hepatitis B- The Case of The University of Naples Federico II

    Nov 1, 2016, 00:00

  • Can We Predict Adherence in Diabetes Patients Based on Medication Characteristics?

    Nov 1, 2016, 00:00

  • A Clinical Literature Review of Coronary Artery Calcification and Current Treatment Outcomes in Japan

    Nov 1, 2016, 00:00

  • The Utilization of Health Services By The Older Europeans- An Econometric Analysis

    Nov 1, 2016, 00:00

  • The Potential Public Health Impact of Varicella Vaccination in Hungary

    Nov 1, 2016, 00:00

  • Economic Analysis of Scaling Up Access to Modern Family Planning Methods in Low and Middle-Income Countries; Case Studies for Indonesia and Uganda

    Nov 1, 2016, 00:00

  • Exploring Determinants Of Polypharmacy In The Elderly Population In Austria

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Regorafenib In Gastrointestinal Stromal Tumours In England Using Crossover Adjustment Methods

    Nov 1, 2016, 00:00

  • Estimation of The Budget Saving Potential Due To The Introduction of Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Spain

    Nov 1, 2016, 00:00

  • The Declining Value of Economics in Canadian Cancer Reimbursement Reviews

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of Secukinumab In The Management of Ankylosing Spondylitis In Greece

    Nov 1, 2016, 00:00

  • Estimating the Economic Impact Due to Productivity Losses of Diabetes and Major Depressive Disorder in Singapore- Human Capital Versus Friction cost Approaches

    Nov 1, 2016, 00:00

  • Workload Analysis And Staffing Requirement Of Clinical Pharmacy Services At Ministry Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • The Effectiveness of Pre-Filled Versus Manually Filled Flush Syringes in Intravascular Devices Maintenan A Meta-Analysis

    Nov 1, 2016, 00:00

  • Trend Towards Longer Time to Reimbursement in Oncological Medicines in Finland 2005-2015

    Nov 1, 2016, 00:00

  • National Survey of Drug Information Centers Practice in Saudi Arabia- Evidence Based Medicine-Therapeutics Guidelines System (Ebm-Tg) At Moh

    Nov 1, 2016, 00:00

  • Estimating Study Costs For Use In Voi, A Study Of Dutch Publicly Funded Drug Related Research

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major Latin-American (LATAM) Markets- Systematic Evaluation in 5 Latam Countries

    Nov 1, 2016, 00:00

  • Prescription Trend in Antihypertensive Drugs in Mumbai And Suburbs- A Survey

    Nov 1, 2016, 00:00

  • Substitutability of Dry Powder Inhalers- A Perspective from German Pulmonologists

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Biosimilar Infliximab (Inflectra ®) For The Treatment of Ankylosing Spondylitis In Nine European Countries

    Nov 1, 2016, 00:00

  • Patient Compliance to Treatment with Gliclazide for Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Patient Individual Therapy as Appropriate Comparator in Amnog-Dossiers in The Field of Oncology- Status Quo and Strategic Implications For Pharmaceutical Companies

    Nov 1, 2016, 00:00

  • Diversity in Economic Evaluations Hampers Valid Decision-Making in Metastatic Colorectal Cancer

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Burns Management in Nigeria- A Case Study of National Orthopaedic Hospital, Enugu

    Nov 1, 2016, 00:00

  • The Effects Of Food Prices On Weight Outcomes. A Systematic Review Of The Moderating Effects Of Income And Initial BMI

    Nov 1, 2016, 00:00

  • Feasibility of Matching-Adjusted Indirect Comparison (MAIC) of Omalizumab (OMA) vs. Mepolizumab (Mepo) in Moderate-to-Severe Asthma

    Nov 1, 2016, 00:00

  • Prescription Data in Australia- How Useful is this ‘Big' Data?

    Nov 1, 2016, 00:00

  • International Reference Pricing- Measuring Country Influence

    Nov 1, 2016, 00:00

  • The Effects of Pay for Response and Maximum Price CAP Schemes on Payer and Provider Risk

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The use of Rivaroxaban in Treatment of Venous Thromboembolism in Spain

    Nov 1, 2016, 00:00

  • Increase Hospital Physicians’ Awareness of Expenditure Generated by Their Prescription in the Ambulatory Sector- Learning from the Experience of the 37 Public Hospitals of Paris in Diabetology

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in Italy

    Nov 1, 2016, 00:00

  • Comparative Analysis of Consumption of Antipsychotic Drugs For Treating Schizophrenia in Hospitals in Russian Federation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Different Biologic Agents For Ankylosing Spondylitis Treatment In Russia

    Nov 1, 2016, 00:00

  • Retrospective Review of Observational Data Requested by the French Health and Technology Assessment Agency- How are Results Taken Into Account?

    Nov 1, 2016, 00:00

  • The Mosaic Study- Regional Variation in Treatment Patterns Associated with Progression from Initial Insulin Regimen

    Nov 1, 2016, 00:00

  • Prevalence of Severe Asthma and Poorly Controlled Severe Asthma During 2009–2013 in The Netherlands

    Nov 1, 2016, 00:00

  • Innovation - A Value For Health And Growth, An International Study On Market Access Stakes For Therapeutic Innovation

    Nov 1, 2016, 00:00

  • A Meta Regression Analysis of Utility Weights for Breast Cancer

    Nov 1, 2016, 00:00

  • Cost Study of Respiratory System Diseases

    Nov 1, 2016, 00:00

  • Recreational Use of Phosphodiesterase 5 Inhibitors and Its Associated Factors Among Undergraduate Male Students In An Ethiopian University- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • The Added Value of Real-World Evidence to Connect Disconnected Networks for Network Meta-Analysis- A Case Study in Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of On-Pump and Off-Pump Stable Multivessel Coronary Artery Bypass Grafting–mass iii 5-Year Follow-Up

    Nov 1, 2016, 00:00

  • Effectiveness Factors In HTA Reports Concerning Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Hepatitis C – Real World Effectiveness of HCV Treatment in Poland

    Nov 1, 2016, 00:00

  • Fixed-Dose Combination Drugs Undergoing Amnog - Learnings from 5 Years

    Nov 1, 2016, 00:00

  • Economic Analysis of Evarrest Sealant Matrix Compared with Standard of Care in Severe Soft Tissue Surgical Bleeding- A France Hospital Perspective

    Nov 1, 2016, 00:00

  • Toward A New Business Model for Biosimilars

    Nov 1, 2016, 00:00

  • Criteria Driving Values Assessments in Multiple Sclerosis Medicines

    Nov 1, 2016, 00:00

  • The Impact of Age- And Gender- Differences In Direct Hospitalization Costs for Hemorrhagic Stroke In-Patients with Basic Medical Insurance Scheme For Urban Residents of China

    Nov 1, 2016, 00:00

  • Pharmacists Manpower Analysis In Years 2006-2014 At Minstery Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • A Regional Analysis of Relapsing Remitting MS (RRMS) Patients Treated with Natalizumab Suggests a Need to Diagnose and Treat Early in Latin Americans

    Nov 1, 2016, 00:00

  • A Parallel Observational and Prospective Study on Pharmacoeconomic Analysis and Prescribing Pattern of Antibiotics in Infectious Diseases

    Nov 1, 2016, 00:00

  • Analysis Of Expenditure In Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2015 In Spain

    Nov 1, 2016, 00:00

  • Real Life Data Demonstrate Significant Reductions In HBA1C In T2DM Patients Switching From Other Insulins To Insulin Degludec

    Nov 1, 2016, 00:00

  • Evaluation Of The Clinical Characteristics And Economic Burden Of United States Veteran Patients Diagnosed With The Hepatitis C Virus

    Nov 1, 2016, 00:00

  • A Conceptual Approach For Including Productivity Losses In Health Economic Evaluations From A Societal Viewpoint

    Nov 1, 2016, 00:00

  • Factors Associated with the Use of Complementary Medicines in Hypertension

    Nov 1, 2016, 00:00

  • Attribute Development Using Continuous Stakeholder Engagement to Prioritize Treatment Decisions- A Framework for Patient-Centered Research

    Sep 1, 2016, 00:00

  • Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life

    Sep 1, 2016, 00:00

  • Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30

    Sep 1, 2016, 00:00

  • When Future Change Matters- Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices

    Sep 1, 2016, 00:00

  • Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy

    Sep 1, 2016, 00:00

  • Economic Impact of Integrated Care Models for Patients with Chronic Diseases- A Systematic Review

    Sep 1, 2016, 00:00

  • Response to Editorial- Estimating Health-State Utility for Economic Models in Clinical Studies- An ISPOR Good Research Practices Task Force Report

    Sep 1, 2016, 00:00

  • The Capability Approach- A Critical Review of Its Application in Health Economics

    Sep 1, 2016, 00:00

  • Estimating Health-State Utility for Economic Models in Clinical Studies- An ISPOR Good Research Practices Task Force Report

    Sep 1, 2016, 00:00

  • Did It Matter That the Cancer Drugs Fund Was Not NICE? A Retrospective Review

    Sep 1, 2016, 00:00

  • A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research- The Key Principles for Informing Coverage Decisions

    Sep 1, 2016, 00:00

  • Developing a Patient-Centered Benefit-Risk Survey- A Community-Engaged Process

    Sep 1, 2016, 00:00

  • Increasing Patient Involvement in Drug Development

    Sep 1, 2016, 00:00

  • A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies

    Sep 1, 2016, 00:00

  • First and Foremost Battle the Virus- Eliciting Patient Preferences in Antiviral Therapy for Hepatitis C Using a Discrete Choice Experiment

    Sep 1, 2016, 00:00

  • International Experiences in Quantitative Benefit-Risk Analysis to Support Regulatory Decisions

    Sep 1, 2016, 00:00

  • Patient Preferences in Regulatory Benefit-Risk Assessments- A US Perspective

    Sep 1, 2016, 00:00

  • Measuring High-Risk Patients’ Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction- A Discrete Choice Experiment

    Sep 1, 2016, 00:00

  • Decision Modeling for Cost-Utility Analysis

    Sep 1, 2016, 00:00

  • Table of Contents

    Sep 1, 2016, 00:00

  • Cost-Effectiveness of Rotavirus Vaccination in France—Accounting for Indirect Protection

    Sep 1, 2016, 00:00

  • Adherence to Self-Care Behaviors among Patients with Type 2 Diabetes—The Role of Risk Preferences

    Sep 1, 2016, 00:00

  • Copyright/Subscription

    Sep 1, 2016, 00:00

  • Instructions for Authors

    Sep 1, 2016, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87 (current)
  • 88
  • 89
  • 90
  • »